CN101352450A - Prescription of compound external-use ulcer powder - Google Patents
Prescription of compound external-use ulcer powder Download PDFInfo
- Publication number
- CN101352450A CN101352450A CNA2008101399850A CN200810139985A CN101352450A CN 101352450 A CN101352450 A CN 101352450A CN A2008101399850 A CNA2008101399850 A CN A2008101399850A CN 200810139985 A CN200810139985 A CN 200810139985A CN 101352450 A CN101352450 A CN 101352450A
- Authority
- CN
- China
- Prior art keywords
- ulcer
- grams
- compound
- berberine
- cimetidine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention relates to a formulation of a compound anti-ulcer pulvis for external application and is characterized in that: the ingredients include terramycin, berberine, compound sinomin, metronidazole, CoVB, VC, cimetidine, calcium and chlorpheniramine; and the proportion of the ingredients is as follows: 15% of terramycin, 15% of berberine, 15% of CoVB, 15% of VC, 10% of compound sinomin, 10 % of metronidazole, 10% of cimetidine, 7% of calcium and 3% of chlorpheniramine. With good curative effects and quick action, the formulation of the compound anti-ulcer pulvis for external application solves the problems that other anti-ulcer pulvis for external application has poor curative effects on some serious oral ulcer and can not be applied to the treatment of other skin diseases such as bedsore, mucocutaneous ulcer, scald, non-healing wounds, and the like, and is especially suitable for the treatment of the skin diseases like bedsore and other mucocutaneous ulcer, scald, non-healing wounds, etc.
Description
Technical field
The present invention relates to medicine and manufacture the field, a kind of specifically pharmaceutical formulation that is used for the skin ulcer treatment.
Background technology
At present common external-use ulcer is dispersed in very big limitation is arranged on therapeutic domain and the effect, and is undesirable to some serious oral ulcer curative effects, and can not be used for the treatment of dermatopathies such as other mucocutaneous ulcer such as decubital ulcer and scald, non-healing wounds.
Summary of the invention
The present invention is dispersed in very big circumscribed problem is arranged on therapeutic domain and the effect for solving other external-use ulcer, invent a kind of preparation that can be used for the compound external-use ulcer powder that dermatopathies such as various skin mucosal ulcer such as oral cavity, decubital ulcer and scald, non-healing wounds treat.
The present invention is for solving the problems of the technologies described above, and the technical scheme of being taked is that a kind of prescription of compound external-use ulcer powder comprises:
Constituent is: oxytetracycline, berberine, bactrim, metronidazole, C
oV
B, V
C, cimetidine, calcium, chlorphenamine;
Component ratio is: oxytetracycline 15%, berberine 15%, C
oV
B15%, V
C15%, bactrim 10%, metronidazole 10%, cimetidine 10%, calcium 7%, chlorphenamine 3%;
Technological process is: claim medicine → grinding → screening → packing.Claim medicine: take by weighing above-mentioned various medicine (tablet gram number) in proportion; Grind: the medicine pulverize that will take by weighing in proportion; Screening: drug powder is crossed sieve No. 6, and mix homogeneously; Packing: drug powder garbled, mix homogeneously is carried out packing.
During use, this drug powder is coated with on the ulcer skin that is sprinkling upon debridement, disinfection equably; The oral cavity can directly be coated with and spread.Consumption: one day twice is suitable to cover wound surface thinly at every turn, too not thick.Points for attention: individually to the careful usefulness of sulfonamide allergy sufferers.
Technique effect
Technique effect of the present invention is, adopts above-mentioned technical scheme, can realize a kind of compound external-use ulcer powder for the treatment of dermatopathies such as mucocutaneous ulcers such as oral cavity, decubital ulcer and scald, non-healing wounds.
Character: this product is a pale yellow powder, bitter in the mouth;
Function with cure mainly: function: anti-inflammatory analgetic, the convergence granulation promoting; Cure mainly: dermatopathies such as oral ulcer, decubital ulcer, scald, non-healing wounds;
Curative effect: coat and take effect immediately, can fully recover in several days, do not have and untoward reaction occurred.
The specific embodiment
Embodiment 1:
Take by weighing oxytetracycline 10 grams, berberine 10 grams, C
oV
B10 grams, V
C10 grams, bactrim 6.7 grams, metronidazole 6.7 grams, cimetidine 6.7 grams, calcium 4.7 grams, chlorphenamine 0.2 gram;
With the said medicine pulverize that takes by weighing in proportion;
The drug powder that is ground into is crossed sieve No. 6, and mix homogeneously, promptly be prepared into 65 gram compound external-use ulcer powders.
Embodiment 2:
Take by weighing oxytetracycline 15 grams, berberine 15 grams, C
oV
B15 grams, V
C15 grams, bactrim 10 grams, metronidazole 10 grams, cimetidine 10 grams, calcium 7 grams, chlorphenamine 3 grams;
With the said medicine pulverize that takes by weighing in proportion;
The drug powder that is ground into is crossed sieve No. 6, and mix homogeneously, promptly be prepared into 100 gram compound external-use ulcer powders.
Embodiment 3:
Take by weighing oxytetracycline 20 grams, berberine 20 grams, C
oV
B20 grams, V
C20 grams, bactrim 13.3 grams, metronidazole 13.3 grams, cimetidine 13.3 grams, calcium 9.3 grams, chlorphenamine 4 grams;
With the said medicine pulverize that takes by weighing in proportion;
The drug powder that is ground into is crossed sieve No. 6, and mix homogeneously, promptly be prepared into 133.2 gram compound external-use ulcer powders.
Claims (2)
1, a kind of prescription of compound external-use ulcer powder is characterized in that: constituent is oxytetracycline, berberine, bactrim, metronidazole, C
oV
B, V
C, cimetidine, calcium, chlorphenamine.
2, the prescription of a kind of compound external-use ulcer powder according to claim 1 is characterized in that: the constituent ratio is: oxytetracycline 15%, berberine 15%, C
oV
B15%, V
C15%, bactrim 10%, metronidazole 10%, cimetidine 10%, calcium 7%, chlorphenamine 3%.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNA2008101399850A CN101352450A (en) | 2008-09-10 | 2008-09-10 | Prescription of compound external-use ulcer powder |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNA2008101399850A CN101352450A (en) | 2008-09-10 | 2008-09-10 | Prescription of compound external-use ulcer powder |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN101352450A true CN101352450A (en) | 2009-01-28 |
Family
ID=40305624
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNA2008101399850A Pending CN101352450A (en) | 2008-09-10 | 2008-09-10 | Prescription of compound external-use ulcer powder |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101352450A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109172583A (en) * | 2018-08-27 | 2019-01-11 | 康宗华 | A kind of pharmaceutical composition for burn and scald knife wound and preparation method thereof and purposes |
-
2008
- 2008-09-10 CN CNA2008101399850A patent/CN101352450A/en active Pending
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109172583A (en) * | 2018-08-27 | 2019-01-11 | 康宗华 | A kind of pharmaceutical composition for burn and scald knife wound and preparation method thereof and purposes |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2008140200A1 (en) | External compositions for the skin | |
| JP2010540542A (en) | Power generation particles and their use | |
| CN1201676A (en) | Cosmetical face film with Chinese medicines | |
| CN102526246A (en) | Externally-used ointment for relieving paronychia pain | |
| Dua et al. | Antimicrobial efficacy of extemporaneously prepared herbal mouth-washes | |
| TW201622738A (en) | Use of plectranthus amboinicus extract for preparing anti-acne composition | |
| CN101612278A (en) | The medicine for external use of treatment pyogenic type contaminated wounds | |
| CN101352450A (en) | Prescription of compound external-use ulcer powder | |
| CN101468045A (en) | Spray powder for treating mouth ulcer and preparation method thereof | |
| CN103830267A (en) | Compound external anti-ulcer tablet | |
| CN101564426B (en) | Medicament for external use for treating onychomycosis | |
| CN1436567A (en) | Burn treating medicine powder | |
| CN101890045B (en) | External medicament for treating infantile eczema | |
| CN102319324B (en) | Medicine for treating beriberi | |
| CN100441181C (en) | Method for preparing micropill capsule of salvia miltiorrhiza bge, and gynostemma pentaphyllum, and its use | |
| CN104688768A (en) | External ulcer powder | |
| CN1030184A (en) | The manufacture method of anti-inflammation medicine | |
| CN101375837B (en) | Medicament composition for treating dermatopathy as well as preparation method and use thereof | |
| CN104510865A (en) | Traditional Chinese medicine powder for treating bedsore | |
| CN1686293A (en) | Paste preparation for treating oxide lichen and its preparation technology | |
| RU2690945C2 (en) | Method for treating skin diseases, burns, superficial and deep wounds | |
| CN102058670A (en) | Oral ulcer powder | |
| CN101125179A (en) | Wound-healing muscle-growing ointment and production method thereof | |
| CN107929312A (en) | A kind of external-use ulcer composite medicine | |
| CN105640979A (en) | Ulcer treating powder for external use |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Open date: 20090128 |